Literature DB >> 14792726

Controlled observations on the effect of low sodium dietotherapy in essential hypertension.

A C CORCORAN, R D TAYLOR, I H PAGE.   

Abstract

Entities:  

Keywords:  BLOOD PRESSURE, HIGH; SODIUM

Mesh:

Substances:

Year:  1951        PMID: 14792726     DOI: 10.1161/01.cir.3.1.1

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

1.  Clinical connotations of the experimental hypertensions.

Authors:  A C CORCORAN
Journal:  Can Med Assoc J       Date:  1959-08-01       Impact factor: 8.262

2.  Reactivity of renal and systemic circulations to vasoconstrictor agents in normotensive and hypertensive subjects.

Authors:  E A GOMBOS; W H HULET; P BOPP; D S BALDWIN; H CHASIS
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

3.  Metabolic effects of marked sodium restriction in hypertensive patients: changes in total exchangeable sodium and potassium.

Authors:  L K DAHL; B G STALL; G C COTZIAS
Journal:  J Clin Invest       Date:  1954-10       Impact factor: 14.808

Review 4.  High blood pressure--ancient, modern and natural.

Authors:  R G Sinclair
Journal:  J R Coll Gen Pract       Date:  1969-10

Review 5.  The nutritional aspects of hypertension and its reversibility.

Authors:  W S Hartroft
Journal:  Am J Public Health Nations Health       Date:  1966-03

Review 6.  Dietary interventions for heart failure in older adults: re-emergence of the hedonic shift.

Authors:  Jeffrey D Wessler; Scott L Hummel; Mathew S Maurer
Journal:  Prog Cardiovasc Dis       Date:  2014-03-12       Impact factor: 8.194

Review 7.  Dietary salt restriction and blood pressure in clinical trials.

Authors:  Daniel T Lackland; Brent M Egan
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

8.  Aldosterone and in vivo mineralocorticoid activity in normotensive and hypertensive man.

Authors:  F Skrabal
Journal:  J R Soc Med       Date:  1979-04       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.